| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,640 |
4,256 |
$181K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,594 |
4,148 |
$117K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,828 |
1,099 |
$91K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
288 |
169 |
$8K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
5,582 |
1,532 |
$8K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
617 |
110 |
$4K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
93 |
87 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
50 |
44 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
29 |
$2K |
| 82962 |
|
1,946 |
1,403 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
44 |
13 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,421 |
1,181 |
$2K |
| 90756 |
|
117 |
97 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
74 |
66 |
$927.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
466 |
266 |
$740.14 |
| 99220 |
|
15 |
13 |
$506.25 |
| 90686 |
|
37 |
32 |
$430.76 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
13 |
$415.77 |
| 99305 |
|
30 |
23 |
$388.50 |
| 99307 |
|
522 |
169 |
$383.46 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
38 |
29 |
$363.36 |
| 92250 |
|
17 |
13 |
$322.95 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
130 |
82 |
$177.80 |
| 81003 |
|
90 |
64 |
$92.25 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58 |
42 |
$48.47 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
56 |
38 |
$0.00 |
| 1159F |
|
778 |
415 |
$0.00 |
| 1160F |
|
1,975 |
1,060 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,867 |
1,035 |
$0.00 |
| 3078F |
|
1,425 |
802 |
$0.00 |
| 3077F |
|
389 |
213 |
$0.00 |
| 2024F |
|
17 |
12 |
$0.00 |
| 1158F |
|
1,895 |
1,037 |
$0.00 |
| 99490 |
Ccm add 20min |
76 |
41 |
$0.00 |
| 4040F |
|
24 |
12 |
$0.00 |
| 4551F |
|
530 |
263 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
79 |
55 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
105 |
72 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
202 |
139 |
$0.00 |
| 4004F |
|
29 |
16 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
18 |
17 |
$0.00 |
| 3079F |
|
1,289 |
742 |
$0.00 |
| 3044F |
|
97 |
46 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
391 |
218 |
$0.00 |
| 1126F |
|
1,099 |
632 |
$0.00 |
| 1170F |
|
654 |
386 |
$0.00 |
| 3008F |
|
975 |
542 |
$0.00 |
| 1036F |
|
2,001 |
1,173 |
$0.00 |
| 3080F |
|
243 |
138 |
$0.00 |
| 3074F |
|
1,880 |
1,057 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
94 |
64 |
$0.00 |
| 3075F |
|
574 |
330 |
$0.00 |
| 1034F |
|
187 |
95 |
$0.00 |
| 1125F |
|
986 |
551 |
$0.00 |
| 1220F |
|
1,067 |
595 |
$0.00 |
| 1123F |
|
111 |
68 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
20 |
12 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
18 |
13 |
$0.00 |